DRG Market Assessment 보고서
질환 개요 및 예측, 역학 인텔리전스, 바이오시밀러 인텔리전스, China In-depth 등 폭넓은 시장 인텔리전스를 확인해 보세요.
Biosimilars – Current Treatment – Biosimilar Target Product Profiles (Immunology)
To obtain a competitive edge in an ever-growing market, biosimilar manufacturers have been using lower prices in reference to branded products and other biosimilars as a primary strategy to improve…
Immune Checkpoint Inhibitors | Special Topics | Trends and Market Dynamics – Multi Indication | G7 | 2023
Immune checkpoint inhibitors have had a transformative impact in many oncology settings since their entry into the marketplace a little over a decade ago. Their use continues to advance into…
Dry and Wet Age-Related Macular Degeneration | Disease Landscape & Forecast | G7 | 2023
Age-related macular degeneration (AMD) is a degenerative and progressive ocular disease that diminishes central visual acuity as a result of photoreceptor degeneration in the macula. The wet AMD…
Crohn’s Disease – Access & Reimbursement – Access & Reimbursement – Impacts of Biosimilar Adalimumab Launches in Autoimmune Disease (US)
2023 marks a pivotal year for the autoimmune space as numerous releases of biosimilar adalimumab challenge the market dominance of AbbVie’s Humira, one of the best-selling brands in the United…
